Screening for cancer in the post-genomic era: diagnostic innovation and biomedicalisation in comparative perspective

Project Information

CANCERSCREEN

Grant agreement ID: 716689

DOI 10.3030/716689

Project closed

EC signature date 24 February 2017

Start date 1 April 2017

End date 30 September 2022

Funded under

• EXCELLENT SCIENCE - European Research Council (ERC)

Total cost € 1 347 992,00

EU contribution € 1 347 992,00

Coordinated by

THE CHANCELLOR MASTERS AND SCHOLARS OF THE UNIVERSITY OF CAMBRIDGE
United Kingdom

Deliverables

Open Research Data Pilot (1)

Data Management Plan

Participation in the Open Research Data Pilot

Publications

Peer reviewed articles (3)

Dangerous diagnostics? Regulatory reform in the genomic era

Author(s): Kelly Holloway, Fiona A Miller, Alberto Gutierrez, Stuart Hogarth
Published in: BMJ, 2019, Page(s) l640, ISSN 0959-8138
Publisher: British Medical Association
DOI: 10.1136/bmj.l640

Health Canada needs to act on laboratory-developed diagnostics

Author(s): Kelly Holloway, Fiona A. Miller, François Rousseau, Alberto Gutierrez, Stuart Hogarth
Published in: Canadian Medical Association Journal, Issue 191/39, 2019, Page(s) E1067-E1069, ISSN 0820-3946
Publisher: Canadian Medical Association/Association Medical Canadienne
DOI: 10.1503/cmaj.190550

Regulatory niches: Diagnostic reform as a process of fragmented expansion. Evidence from the UK 1990-2018.

Author(s): Stuart Hogarth; Olga Löblová
Published in: Social Science & Medicine, Issue 304, 2020, ISSN 0277-9536
Publisher: Pergamon Press Ltd.
DOI: 10.1016/j.socscimed.2020.113363